Hello Confidence: Treat Rosacea and Say Goodbye to Heavy Makeup
We may receive commissions from links on this page, but we only recommend products we love and deem 'redhead friendly'. Full Disclosure.
If you often struggle with redness, bumps and pimples on your face, you know it isn’t a random thing.
It usually worsens with cold and hot weather, and layering thick makeup never makes the issue go away – it only covers it up. You may have even thought you had acne when your skin was actually indicating you had the commonly misunderstood skin condition called rosacea. Rosacea is an inflammatory disorder affecting the face and symptoms manifest differently from patient to patient, so tailored treatment to fit individual needs is key.
We want each and every one of you to feel confident about your skin (and red hair), so that’s why we wanted to tell you about the Break Up with Your Makeup Program.
It’s empowering anyone who struggles with rosacea, or thinks they might have it, to kick their makeup to the curb by sharing a no makeup selfie showing how you stay confident even on “tough skin days.”
ENTER YOUR EMAIL BELOW or ENTER HERE for a chance to win an all-expense paid trip for two to the Fall 2015 New York Film Festival.
And, make sure to use the hashtag #BreakUpWMakeup, and you may just be featured on How to be a Redhead’s social outlets, too.
Did you know there are actually treatments for rosacea? It’s true!
So drop the concealer and visit a dermatologist today to ask if any of these treatments may be right for you:
SOOLANTRA® (ivermectin) Cream, 1% is a once-daily, prescription topical treatment for the inflammatory lesions of rosacea. Soolantra Cream may start working as quickly as week two, with continuous improvement with long-term use.
MIRVASO® (brimonidine) topical gel, 0.33% is the first and only prescription treatment specifically developed and indicated to treat the persistent facial redness of rosacea. Apply Mirvaso Gel to your face once daily and it may start working in as little as 30 minutes. Mirvaso Gel won’t just cover up redness, it may reduce redness for up to 12 hrs.
ORACEA® (doxycycline, USP) 40 mg is the one and only pill approved by the FDA for the treatment of the bumps and pimples of rosacea. Oracea Capsule works from within to target and treat the inflammatory lesions of rosacea in adults.
[Sponsored Post: This post is part of the Break Up with Your Makeup program sponsored by Galderma Laboratories, L.P. You should discuss any medications with your doctor.
Important Safety Information – Soolantra® Cream
Indication: SOOLANTRA® (ivermectin) Cream, 1%, is indicated for the treatment of inflammatory lesions of rosacea. Adverse Events: In clinical trials with SOOLANTRA Cream, the most common adverse reactions (incidence ≥ 1 %) included skin burning sensation and skin irritation. Warnings / Precautions: Not for oral, ophthalmic or intravaginal use.Important Safety Information – Mirvaso® Gel*
Indication: Mirvaso® (brimonidine) topical gel, 0.33% is an alpha-2 adrenergic agonist indicated for the topical treatment of persistent (nontransient) facial erythema of rosacea in adults 18 years of age or older. Adverse Events: In clinical trials, the most common adverse reactions (≥1%) included erythema, flushing, skin-burning sensation and contact dermatitis. Warnings/Precautions: Mirvaso Gel should be used with caution in patients with depression, cerebral or coronary insufficiency, Raynaud’s phenomenon, orthostatic hypotension, thromboangiitis obliterans, scleroderma, or Sjögren’s syndrome. Alpha-2 adrenergic agents can lower blood pressure. Mirvaso Gel should be used with caution in patients with severe or unstable or uncontrolled cardiovascular disease. Serious adverse reactions following accidental ingestion of Mirvaso Gel by children have been reported. Keep Mirvaso Gel out of reach of children. Not for oral, ophthalmic, or intravaginal use.
*Each gram of gel contains 5mg of brimonidine tartrate, equivalent to 3.3 mg of brimonidine free base
Important Safety Information (Oracea® Capsules)
Indication: ORACEA® (doxycycline, USP) 40 mg** Capsules are indicated for the treatment of only inflammatory lesions (papules and pustules) of rosacea in adult patients. ORACEA Capsules do not lessen the facial redness caused by rosacea. Adverse Events: In controlled clinical studies, the most commonly reported adverse events (>2%) in patients treated with ORACEA Capsules were nasopharyngitis, sinusitis, diarrhea, hypertension and aspartate aminotransferase increase. Warnings/Precautions: ORACEA Capsules should not be used to treat or prevent infections. ORACEA Capsules should not be taken by patients who have a known hypersensitivity to doxycycline or other tetracyclines. ORACEA Capsules should not be taken during pregnancy, by nursing mothers, or during tooth development (up to the age of 8 years). Although photosensitivity was not observed in clinical trials, ORACEA Capsules patients should minimize or avoid exposure to natural or artificial sunlight. The efficacy of ORACEA Capsules treatment beyond 16 weeks and safety beyond 9 months have not been established.